Concepedia

<sup>90</sup>Y-DOTATOC as a Therapeutic Option for Complex Recurrent or Progressive Meningiomas

Karine Gerster-Gilliéron, Flavio Forrer, Helmut R. Maëcke, Jan Mueller‐Brand, Adrian Merlo, Dominik Cordier

Journal of Nuclear Medicine · 2015 · 64 citations · 16 references

DOIFull text

Open access

Abstract

(90)Y-DOTATOC therapy is feasible and may represent a promising second- or third-line option for complex meningiomas, which are progressive or otherwise not treatable with a reasonable risk-benefit ratio.

References

16

Treatment of patients with gastro-entero-pancreatic (GEP) tumours with the novel radiolabelled somatostatin analogue [177Lu-DOTA0,Tyr3]octreotate

Dik J. Kwekkeboom, Willem H. Bakker, Boen L.R. Kam et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2003 · 418 citations · Full text

, , +6

Stereotactic radiosurgery providing long-term tumor control of cavernous sinus meningiomas

John Y. K. Lee, Ajay Niranjan, James McInerney et al. · Journal of neurosurgery · 2002 · 400 citations

The clinical value of [90Y-DOTA]-D-Phe1-Tyr3-octreotide (90Y-DOTATOC) in the treatment of neuroendocrine tumours: A clinical phase II study

Christian Waldherr, Misha Pless, Helmut R. Maëcke et al. · Annals of Oncology · 2001 · 394 citations

, , +7

Stereotactic radiosurgery provides equivalent tumor control to Simpson Grade 1 resection for patients with small- to medium-size meningiomas

Bruce E. Pollock, Scott L. Stafford, Andrew Utter et al. · International Journal of Radiation Oncology*Biology*Physics · 2003 · 325 citations

, , +9

Long-term Tumor Control of Benign Intracranial Meningiomas After Radiosurgery in a Series of 4565 Patients

Antonio Santacroce, Maja Walier, Jean Régis et al. · Neurosurgery · 2011 · 241 citations